Evolution of interactions between Wolbachia and its hosts: Drosophila model syste
Evolution of interactions between Wolbachia and its hosts: Drosophila model syste
批准号:
9126575
负责人:
Michael Turelli
金额:
$39.46万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-20 至 2019-08-31
关键词:
AccountingAgeAmericanAustraliaBacteriaBiological AssayBiological ModelsBiologyCaliforniaCellsCellular biologyComplementCulicidaeDengueDiseaseDisease VectorsDrosophila genusDrug or chemical Tissue DistributionEmbryoEventEvolutionExhibitsFemaleFertilityFoundationsFrequenciesGeneticGenomeGoalsHaplotypesHealthHumanInfectionInheritedInsectaKnowledgeLaboratoriesLifeLongevityMaintenanceMalariaMicroinjectionsMitochondrial DNAModelingMolecularNatureNorth AmericaPartner in relationshipPhylogenyPopulationPopulation BiologyPopulation DynamicsReproductionResearchSystemTechniquesTestingTimeVariantVector-transmitted infectious diseaseVertical Disease TransmissionVirusWalkersWest Nile virusWolbachiaWorkbasecomparative genomicsdisease transmissionfield surveyfitnessgenomic toolsgenomic variationhealth applicationhuman diseaseinvertebrate hostkillingslaboratory experimentmalemortalitymutualismpathogenpopulation surveyreproductiveresearch studystudy populationtransmission processvector mosquito
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Project: Evolution of interactions between Wolbachia and its hosts: Drosophila model systems. Project Summary: Wolbachia are bacteria that live inside cells of their invertebrate hosts. They are generally maternally transmitted and often spread through populations by manipulating host reproduction. Their most commonly documented reproductive manipulation is "cytoplasmic incompatibility" (CI), increased embryo mortality when infected males mate with uninfected females. CI drives Wolbachia into populations and is being used to introduce into natural mosquito populations Wolbachia strains that suppress disease-causing viruses (particularly dengue fever). With their ability to block pathogen transmission, Wolbachia hold significant promise for controlling many diseases transmitted between humans by insects, including malaria and West Nile virus. Because Wolbachia are maternally inherited, they evolve to help their hosts survive and reproduce, for instance, by suppressing pathogens and increasing host fecundity. Conversely, because Wolbachia reproductive manipulations kill embryos, hosts may evolve to suppress these deleterious effects (without compromising beneficial effects). Health applications of Wolbachia depend on understanding their spread in nature and the potential for rapid Wolbachia-host coevolution. Knowledge of Wolbachia-host interactions in nature is limited to a handful of model systems. Wolbachia infections of Drosophila provide paradigms for understanding rapid spatial spread of Wolbachia, coevolutionary change, and the molecular mechanisms underlying these phenomena. Two of the best understood Wolbachia infections are those in D. simulans (especially wRi) and D. melanogaster (wMel). These infections persist in nature by fundamentally different mechanisms, with only wRi-simulans fully explained. Yet, the wMel-melanogaster association is apparently much older. This project aims to develop a deep understanding of Wolbachia population dynamics and evolution by: (1) expanding field and laboratory analyses of wRi-simulans and wMel-melanogaster, and (2) describing Wolbachia-host interactions and coevolution using at least 30 additional Drosophila species with Wolbachia infections. Tools from genomics, cell biology and evolutionary genetics, already optimized for Drosophila, will be used to study population and evolutionary dynamics in nature. For instance, microinjection techniques will move Wolbachia between Drosophila species and disentangle Wolbachia from host effects. Over the past 20 years, wRi and wMel have spread in Australia, and wRi has evolved in California. These current events provide a unique opportunity to follow population and evolutionary dynamics in action. Over 30 additional Drosophila species, known to carry Wolbachia, will be studied in detail to understand more generally the trajectory, time-scale and mechanisms of coevolution between Wolbachia and their hosts. The proposed research, based on a combination of field surveys, field and laboratory experiments, comparative genomics and lab assays of phenotypic effects, will provide the foundation for understanding likely Wolbachia trajectories in other systems, including applications to mosquito vectors of disease.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s12866-019-1579-3
发表时间:
2019-09-03
期刊:
BMC MICROBIOLOGY
影响因子:
4.2
作者:
[Christensen, Steen, Camacho, Moises, Serbus, Laura R.]
通讯作者:
Serbus, Laura R.
Evolution of interactions between Wolbachia and its hosts: Drosophila model syste
-
批准号:8734450
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Michael Turelli
-
依托单位:
Evolution of interactions between Wolbachia and its hosts: Drosophila model syste
-
批准号:8421766
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2013
-
负责人:Michael Turelli
-
依托单位:
Evolution of interactions between Wolbachia and its hosts: Drosophila model syste
-
批准号:8919918
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2013
-
负责人:Michael Turelli
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: